Mano Manoharan

Alnylam Pharmaceuticals, USA

V. Narry Kim

Seoul National University, Korea

Jin-Soo Kim

KAIST, Korea

Bruce Sullenger

Duke University, USA

Takeshi Wada

Tokyo University of Science, Japan

Jihye Park

Novo Nordisk GNAT, USA

June Hyun Park

OliX Pharmaceuticals, Korea

Young Jun Seo

Elonova, Korea

Hiroshi Abe

Nagoya University, Japan

Kumiko Ui-Tei

Institute of Science Tokyo, Japan

Yoosik Kim

KAIST, Korea

Jinha Yu

Ewha Womans University, Korea

Ron Batra

Dyne Therapeutics, USA

Dae-Ro Ahn

KIST, Korea

Long-Cheng Li

Ractigen Therapeutics, China

Wensheng Wei

Peking University, China

S. Chul Kwon

The University of Hong Kong, Hong Kong, China

Seung Ryul Han

Rznomics, Korea

Hanna Suh

Korea Institute of Toxicology, Korea

Ichiro Hirao

Xenolis Pte Ltd, Singapore

Jeong Ho Lee

KAIST, Korea

Il-Hoan Oh

RegenInnopharm, Korea

Tae-Won Kim

Ionis Pharmaceuticals, USA

Ik-Hyeon Paik

Wave Life Sciences, USA

Thomas Rupp

Thomas Rupp Consulting UG, Germany